NCT06453746 Effectiveness of Non-pharmacological Interventions for Dementia Prevention in Elderly Patients With Mild Cognitive Impairment
| NCT ID | NCT06453746 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Gia Dinh People Hospital |
| Condition | Mild Cognitive Impairment |
| Study Type | INTERVENTIONAL |
| Enrollment | 192 participants |
| Start Date | 2024-08-26 |
| Primary Completion | 2026-10 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 192 participants in total. It began in 2024-08-26 with a primary completion date of 2026-10.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The aims of this study is to evaluate the effectiveness of non-pharmacological interventions program in preventing progression from mild cognitive impairment to dementia in patients with mild cognitive impairment in the short term, at Nhân dân Gia Định Hospital, Hồ Chí Minh City.
Eligibility Criteria
Inclusion Criteria: * Subjects diagnosed with mild cognitive impairment: * Cognitive complaints from the subject or a family member. * Report a decline in cognitive function compared to the subject's previous ability over the past year OR * Evidence from clinical assessment, specifically here is MMSE screening with results of 24-29 points. * Subjects did not suffer major impacts from cognitive complaints on daily life. * No prior diagnosis of dementia. * Ensure transportation from living location to hospital. * Have at least one relative or caregiver who can supervise the subject's daily activities. * Stable chronic underlying conditions (diabetes, hypertension). * Consent to participate in the study. Exclusion Criteria: * Don't know Vietnamese writing. * Audio-visual ability does not meet the requirements of assessment tests and prevention programs. * Systemic diseases are contraindications/ restriction to participation in programs and/or cause secondary cognitive impairment (traumatic brain injury, stroke, brain tumor, parkinsonism, epilepsy, acute coronary artery disease, acute myocardial infarction, bone fractures...). * The assessment score on the Geriatric Depression Scale (GDS-15) is ≥ 5 points. * Diagnosed with other mental disorders that may limit the ability to understand, communicate and work in groups (schizophrenia, mania, bipolar disorder, dissociative disorder, generalized anxiety disorder). * Currently participating in another research program on dementia prevention or a research program on medication to prevent dementia within the last 3 months. * Taking medications that may affect cognitive function, such as benzodiazepines, hypnotics, and antipsychotics. * Alcohol abuse: drinking alcohol daily or consuming more than 14 units of alcohol per week (equivalent to 10 grams of ethanol, as defined by the Ministry of Health); diagnosed with alcohol dependence or currently being treated for mental illness due to alcohol dependence. * Do not agree to participate in the study.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06453746 clinical trial?
This trial is open to participants of all sexes, aged 60 Years or older, studying Mild Cognitive Impairment. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06453746 currently recruiting?
Yes, NCT06453746 is actively recruiting participants. Contact the research team at nguyenquangkhai2209@gmail.com for enrollment information.
Where is the NCT06453746 trial being conducted?
This trial is being conducted at Ho Chi Minh City, Vietnam.
Who is sponsoring the NCT06453746 clinical trial?
NCT06453746 is sponsored by Gia Dinh People Hospital. The trial plans to enroll 192 participants.